{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05285839",
            "orgStudyIdInfo": {
                "id": "ETC01"
            },
            "organization": {
                "fullName": "Psoriasis Treatment Center of Central New Jersey",
                "class": "OTHER"
            },
            "briefTitle": "Dupixent and Narrowband UVB for Atopic Dermatitis",
            "officialTitle": "Single Center, Pilot Study to Evaluate the Effectiveness and Safety of Dupilumab in Combination With Narrowband UVB (nUVB) Phototherapy in the Treatment of Moderate-to-Severe Atopic Dermatitis",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "dupixent-and-narrowband-uvb-for-atopic-dermatitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-08",
            "studyFirstSubmitQcDate": "2022-03-08",
            "studyFirstPostDateStruct": {
                "date": "2022-03-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-14",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Psoriasis Treatment Center of Central New Jersey",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Regeneron Pharmaceuticals",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "24 weeks open-label study with dupilumab and narrowband UVB phototherapy three times weekly for 12 weeks followed by 12 weeks of dupilumab monotherapy.",
            "detailedDescription": "24 weeks open-label study with dupilumab and narrowband UVB phototherapy three times weekly for 12 weeks followed by 12 weeks of dupilumab monotherapy."
        },
        "conditionsModule": {
            "conditions": [
                "Atopic Dermatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dupixent and Narrowband UVB",
                    "type": "EXPERIMENTAL",
                    "description": "Dupixent and Narrowband UVB",
                    "interventionNames": [
                        "Drug: Dupixent"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dupixent",
                    "description": "dupilumab 300mg",
                    "armGroupLabels": [
                        "Dupixent and Narrowband UVB"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Investigators Global Assessment Score of score of 0 or 1",
                    "description": "Proportion of subjects achieving an IGA score of 0 or 1 with at least a 2 grade improvement at week 12",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female adult \u2265 18 years of age;\n* Diagnosis of moderate to severe atopic dermatitis as defined at baseline by:\n\n  * EASI score of 16 or greater,\n  * IGA score of 3 or greater\n  * BSA of 10% or greater,\n\nExclusion Criteria:\n\n* Subjects with previous exposure to dupilumab.\n* Known or suspected hypersensitivity to dupilumab or any of its excipients.\n* History of photosensitivity.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Elise Nelson",
                    "role": "CONTACT",
                    "phone": "6094434500",
                    "email": "enelson@windsordermatology.com"
                }
            ],
            "locations": [
                {
                    "facility": "Eczema Treatment Center of New Jersey",
                    "status": "RECRUITING",
                    "city": "East Windsor",
                    "state": "New Jersey",
                    "zip": "08520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elise Nelson",
                            "role": "CONTACT",
                            "phone": "609-443-4500",
                            "phoneExt": "1402",
                            "email": "enelson@windsordermatology.com"
                        },
                        {
                            "name": "Jerry Bagel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.268,
                        "lon": -74.54043
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003876",
                    "term": "Dermatitis, Atopic"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000004485",
                    "term": "Eczema"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}